These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21825042)

  • 21. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
    Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
    Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importin-α1 as a novel prognostic target for hepatocellular carcinoma.
    Yoshitake K; Tanaka S; Mogushi K; Aihara A; Murakata A; Matsumura S; Mitsunori Y; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S
    Ann Surg Oncol; 2011 Jul; 18(7):2093-103. PubMed ID: 21286940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the prognosis of hepatocellular carcinoma using gene expression.
    Chang SH; Suh KS; Yi NJ; Lee KH; Kim BY; Jang JJ
    J Surg Res; 2011 Dec; 171(2):524-31. PubMed ID: 20828739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.
    Kang YH; Ji NY; Lee CI; Lee HG; Kim JW; Yeom YI; Kim DG; Yoon SK; Kim JW; Park PJ; Song EY
    Amino Acids; 2011 Mar; 40(3):1003-13. PubMed ID: 20821239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma.
    Yang A; Liu J; Li M; Zhang H; Zhang X; Wu L
    Diagn Pathol; 2024 Aug; 19(1):105. PubMed ID: 39095799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BC047440 overexpression is a risk factor for tumor invasion and poor prognosis in hepatocellular carcinoma.
    Zheng L; Huang X; Liang P; Wen Y; Yang T; Li Y; Zhao H; Han K; Li J
    Hepatogastroenterology; 2010; 57(101):919-25. PubMed ID: 21033252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf-1-ERK1/2-p70S6K signalling pathway.
    Leung TH; Yam JW; Chan LK; Ching YP; Ng IO
    Liver Int; 2010 Oct; 30(9):1315-23. PubMed ID: 20629949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma].
    Song LJ; Ye SL; Wang KF; Weng YQ; Liang CM; Sun RX; Zhao Y; Liu YK; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):428-31. PubMed ID: 15975276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
    Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
    Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma].
    Chen XJ; Wu LM; Xu XB; Feng XW; Xie HY; Zhang M; Shen Y; Wang WL; Liang TB; Zheng SS
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1354-8. PubMed ID: 18241575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
    Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
    Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma.
    Yamashita T; Honda M; Takatori H; Nishino R; Minato H; Takamura H; Ohta T; Kaneko S
    J Hepatol; 2009 Jan; 50(1):100-10. PubMed ID: 19008011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
    Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
    J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
    Ding ZB; Shi YH; Zhou J; Shi GM; Ke AW; Qiu SJ; Wang XY; Dai Z; Xu Y; Fan J
    Cancer; 2009 Oct; 115(20):4753-65. PubMed ID: 19626651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of Krüppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma.
    Li JC; Yang XR; Sun HX; Xu Y; Zhou J; Qiu SJ; Ke AW; Cui YH; Wang ZJ; Wang WM; Liu KD; Fan J
    Gastroenterology; 2010 Dec; 139(6):2146-2157.e12. PubMed ID: 20728449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
    Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
    Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
    Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.